-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Entero Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2021 to Q1 2024.
- Entero Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 14.5M shares, a 12626% increase year-over-year.
- Entero Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 336K shares, a 837% increase from 2022.
- Entero Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 35.9K shares, a 15.5% decline from 2021.
- Entero Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 42.5K shares, a 98.5% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)